Aldosterone synthesis inhibitors in resistant hypertension: the BaxHTN trial.

Gallo G, Volterrani M, Tocci G, Volpe M

Open source

DOI
10.1093/eurheartjsupp/suag049
Published
2026 May
Container
European heart journal supplements : journal of the European Society of Cardiology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/eurheartjsupp/suag049,
  title = {Aldosterone synthesis inhibitors in resistant hypertension: the BaxHTN trial.},
  author = {Gallo G and Volterrani M and Tocci G and Volpe M},
  year = {2026},
  journal = {European heart journal supplements : journal of the European Society of Cardiology},
  doi = {10.1093/eurheartjsupp/suag049},
  url = {https://doi.org/10.1093/eurheartjsupp/suag049}
}

RIS

TY  - JOUR
TI  - Aldosterone synthesis inhibitors in resistant hypertension: the BaxHTN trial.
AU  - Gallo G
AU  - Volterrani M
AU  - Tocci G
AU  - Volpe M
PY  - 2026
JO  - European heart journal supplements : journal of the European Society of Cardiology
DO  - 10.1093/eurheartjsupp/suag049
UR  - https://doi.org/10.1093/eurheartjsupp/suag049
ER  - 

APA

G, G., M, V., G, T., & M, V. (2026). Aldosterone synthesis inhibitors in resistant hypertension: the BaxHTN trial.. European heart journal supplements : journal of the European Society of Cardiology. https://doi.org/10.1093/eurheartjsupp/suag049

Source records